Q4 FY25 Performance - Sales decreased by 8% to $478 million compared to Q4 FY24, but decreased by only 1% compared to the portfolio reset baseline of $484 million[15, 24] - Adjusted EBITDA increased by 110 bps to 249%, but decreased by 4% to $119 million compared to Q4 FY24[15] - Adjusted EPS decreased by 14% to $108[15] Business Unit Performance - Life Sciences sales decreased by 10% to $173 million, but decreased by only 2% compared to the reset results of $177 million; EBITDA margin increased by 260 bps to 318%[25] - Personal Care sales decreased by 7% to $151 million, but increased by 5% compared to the reset results of $143 million; EBITDA margin decreased by 50 bps to 285%[31] - Specialty Additives sales decreased by 9% to $131 million, but decreased by 6% compared to the reset results of $140 million; EBITDA margin increased by 200 bps to 221%[34] - Intermediates sales decreased by 8% to $33 million; EBITDA margin decreased by 1260 bps to 152%[28] Strategic Initiatives & Outlook - The company expects full-year fiscal 2026 sales to be between $1835 million and $1905 million, and adjusted EBITDA to be between $400 million and $430 million[46] - The company is targeting approximately $30 million in savings from restructuring and manufacturing optimization[47] - The company aims to achieve approximately $15 million in sales growth through innovation and approximately $20 million in sales growth through globalization initiatives[47] Financial Position - The company has approximately $08 billion in cash and revolver availability[72] - The company's net debt is $1169 million, with a net leverage of 29x[72]

Financial Performance - Third quarter net income reached $39 million, or $1.49 per share, nearly doubling from the previous year[8] - The combined ratio for the third quarter was 91.9%, and the year-to-date ROE was 12.7%, marking the best results in nearly 20 years[8] - Net investment income increased by 6% due to a 17% growth in fixed maturity income[8] - Adjusted operating income reached $40 million, compared to $21 million in the prior year[5] - Net premiums written grew by 7% to a third quarter record of $328 million[8, 15] Underwriting Performance - The net loss ratio improved by 5 percentage points to 57.3% in the third quarter[5] - The underwriting expense ratio improved to 34.6%, reflecting disciplined expense management and business growth[5, 15] - The catastrophe loss ratio was 1.3% in Q3, outperforming historical averages[5, 15] Production Results - Core commercial net written premium increased 22% from the prior year[17] - Core commercial rate increases moderated to 5.8% while maintaining strong margins[17] Investment Portfolio - Invested assets totaled $2.3 billion, with 89% allocated to fixed income securities[20] - The average credit rating on fixed maturity assets improved to AA[20] - Fixed maturity income increased 17% due to portfolio management and reinvestment at higher yields[21, 24]

Global Expansion & Unit Economics - International adjusted EBITDA is projected to grow 4x from 2022 to 2025F, driven by direct franchising and stronger unit economics[2] - The percentage of rooms under direct franchising is expected to increase from 19% in 2022 to 41% in 2025F[3] - EBITDA per unit is projected to increase from $9,000 in 2022 to $28,000 in 2025F[3] - Adjusted EBITDA is expected to increase from $10 million in 2022 to $39 million in 2025F, a 3x increase[3] Pipeline Composition & Growth Drivers - A new MFA partnership in China is expected to add 9,500 rooms[4] - 98% of the global pipeline is comprised of higher-revenue hotels with higher room count, RevPAR, and royalty rates[5] - Midscale and Extended Stay segments constitute 34% and 39% respectively of the 3Q 2025 Global Portfolio[6] - Conversions make up 35% of the 3Q 2025 Global Pipeline, while new builds account for 65%[6] - Average rooms per unit in the global pipeline are 96, compared to 86 in the global portfolio[6] - Average RevPAR in the global pipeline is $70, compared to $54 in the global portfolio[6] - Conversions are typically opened within 3-6 months, approximately 80% faster than new construction[6]

Financial Performance - Adjusted Operating Earnings Per Share increased to $2.45 in 3Q'25 from $1.90 in 3Q'24[14] - Adjusted Operating Earnings After-Tax increased to $239 million in 3Q'25 from $190 million in 3Q'24[14] - Net Income Available to Common Shareholders increased to $176 million in 3Q'25 from $93 million in 3Q'24[14] - Excess Capital Generation was $0.2 billion in 3Q'25 and the company is on track to exceed the original guidance of $0.7 billion for the year[14] - Retirement's 3Q'25 adjusted operating earnings increased by 20%+ year-over-year[16] - Investment Management's 3Q'25 adjusted operating earnings increased by 13% year-over-year[19] - Employee Benefits' 3Q'25 adjusted operating earnings increased by 104% year-over-year[23] Business Segments - Retirement has Defined Contribution net inflows of $30 billion YTD'25[17] - Investment Management had net inflows of $3.9 billion in 3Q'25, contributing to YTD'25 net inflows of over $13 billion[21] - Investment Management YTD'25 organic growth of 4.4%[21] - Employee Benefits is focused on Stop Loss margin improvement[22] Capital Management - YTD'25 Capital Allocation includes 36% for Strategic Investments, 36% for Share Repurchases & Dividends, and 28% for Excess Capital[32]

Financial Performance - Ardmore Shipping reported adjusted earnings of $12.6 million, or $0.31 per share[9] - The company's cash breakeven is $11,700, and the operating cash breakeven is $10,800[9] - Adjusted EBITDAR was $27.6 million in 3Q 2025[42] - For 4Q 2025, the MR Combined spot TCE is expected to be $24,900 (40% fixed), and the Chemical spot TCE is expected to be $22,200 (35% fixed)[8,66] Market Dynamics - Refined product export volumes increased by 4% QoQ, reaching record levels[18] - Sanctioned fleet represents 16% of the global tanker fleet[24] - 2025 ordering activity is down 80% YoY[25] Fleet and Operations - The company fully redeemed $30 million preferred shares[9] - The company time chartered-out a 2014-built MR for two years at $21,250 per day[9] - The company estimates 2025 fleet capex of $37 million, including elective capex of $16 million[46] - The company achieved 99% on-hire availability in 3Q 2025[46]

Financial Performance - Q4 F2025 - Revenue reached $4.01 billion, a 9.7% increase compared to Q4 F2024[13] - Constant currency revenue growth was 5.5%[13,36] - Adjusted EBIT increased by 11.2% to $667 million, with a margin of 16.6%, up 20 bps from Q4 F2024[13,41] - Adjusted net earnings increased by 7.4% to $472 million[13] - Adjusted diluted EPS increased by 10.9% to $2.13[13,46] Financial Performance - Fiscal Year 2025 - Revenue reached $15.9 billion, an 8.4% increase compared to F2024[32,56] - Constant currency revenue growth was 4.6%[32,56] - Adjusted EBIT increased by 8.1% to $2.61 billion, with a margin of 16.4%[32,64] - Adjusted net earnings increased by 6.0% to $1.87 billion[32] - Adjusted diluted EPS increased by 8.9% to $8.30[32,68] Other Key Metrics - Book-to-bill ratio for Q4 F2025 was 119.2%, and 110.4% for the last twelve months[15,30] - Cash provided by operating activities for Q4 F2025 was $663 million, representing 16.5% of revenue[28] - Long-term debt and lease liabilities reached $4.33 billion, up $1.02 billion from Q4 F2024[49]

3Q'25 Earnings Presentation Forward-Looking Statements The following is a "safe harbor" statement under the Private Securities Litigation Reform Act of 1995: Certain statements and information in this presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding (i) our expectations about our intrinsic value or our prospects for growth and value creation and (ii) our financial outlook, positi ...

Financial Performance - Sales reached $498 million, reflecting 3% organic growth[4] - Adjusted EBITDA was $76 million with a 153% margin[4] - Adjusted EPS stood at $034, compared to $029 in the prior year[4, 11] - The company returned $25 million to shareholders through $10 million in share repurchases and $15 million in dividends[4, 11] Segment and Regional Growth - Metal Cutting and Infrastructure segments both experienced 3% organic growth[11] - Americas region saw a 7% sales growth in constant currency[11] - Aerospace & Defense sector experienced a 20% sales growth[11] Outlook and Restructuring - The company is on track to deliver approximately $35 million in restructuring savings[37, 40] - FY26 sales are projected to be between $210 billion and $217 billion[37] - Adjusted EPS for FY26 is expected to be in the range of $135 to $165[37] Balance Sheet - Net debt was $4949 million[32] - Free Operating Cash Flow (FOCF) was $(5) million[4] - Primary Working Capital as a percentage of sales was approximately 32%[35, 37]

Financial Performance - Core sales increased by 6% CER to $532 million, exceeding the outlook of ≥5%[5,9] - Net sales reached $533 million, a 5% CER increase compared to Q3 2024[5,7] - Adjusted diluted EPS was $0.61 CER, a 7% CER increase, surpassing the outlook of ≥$0.58 CER[5] - Adjusted operating income margin remained steady at 29.6%[5,24] - Operating cash flow for 9M 2025 was $466 million, a 3% decrease[5] Product and Portfolio Developments - QIAstat-Dx and QuantiFERON both experienced 11% CER growth, leading the portfolio[5,8] - Sample technologies showed a 3% CER growth[5,8] - QIAcuity digital PCR and QDI delivered solid contributions[5,8] - Parse Biosciences acquisition is expected to contribute ~$40 million in sales in 2026[22] Outlook and Capital Allocation - The company reaffirmed its 2025 net sales outlook of +4-5% CER (+5-6% CER core growth)[5] - The company increased its adjusted diluted EPS outlook to ~$2.38 CER (previously ~$2.35 CER)[5] - At least $1 billion of returns to shareholders is planned for 2024-28 (absent M&A)[14] - $500 million share repurchase program is authorized for completion in January 2026[15]

SUNCOR ENERGY Investor Information Q3 2025 Published November 4, 2025 SUNCOR ENERGY Suncor's value proposition Long-life, competitively advantaged assets Regional and vertical integration Operational reliability Disciplined investment & cost management Deliver superior long-term shareholder value SUNCOR ENERGY 2 Suncor key statistics | Market capitalization Q3 2025 | $70B | | --- | --- | | Net debt to AFFO Q3 2025 TTM | 0.5x | | Oil sands reserve life index | 2024 25 yrs | | Upgrading capacity | 556 kbpd | ...